The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Inflamm Res. 2010 Aug;59(8):659-66. doi: 10.1007/s00011-010-0178-4. Epub 2010 Mar 9.
The goal of this paper is to investigate the effects of activated complement C5a on vascular endothelium during vessel formation.
A human microvascular endothelial cell line (HMEC-1) derived from post-capillary venules in skin was used to measure DNA synthesis, proliferation and cell-cycle progression. In vitro ring-shaped formation by the cells was assessed by using type I collagen gel matrix and a cell-migration assay using the Chemotaxicell chamber. A Matrigel plug assay was performed to confirm the effect of C5a in vivo.
C5a progressed the cell cycle of HMEC-1 into G2/M phases, and induced DNA synthesis and proliferation in a dose-dependent manner. C5a efficiently induced migration and ring-shaped structure formation both in vitro and in vivo. Furthermore, a C5a receptor antagonist (W-54011) suppressed all HMEC-1 activities including proliferation and migration.
Proliferation, migration, and ring-shaped formation by HMEC-1 cells was induced by C5a. The actions were efficiently inhibited by a specific antagonist against C5a. Our results implicated C5a in vessel formation and as a potent target for management of inflammatory diseases.
本文旨在研究激活的补体 C5a 在血管生成过程中对血管内皮的影响。
使用源自皮肤毛细血管后的人微血管内皮细胞系(HMEC-1)来测量 DNA 合成、增殖和细胞周期进程。通过使用 I 型胶原凝胶基质和 Chemotaxicell 室中的细胞迁移测定来评估细胞的体外环状形成。进行 Matrigel plugs 测定以确认 C5a 在体内的作用。
C5a 将 HMEC-1 的细胞周期推进到 G2/M 期,并以剂量依赖的方式诱导 DNA 合成和增殖。C5a 有效地诱导了体外和体内的迁移和环状结构形成。此外,C5a 受体拮抗剂(W-54011)抑制了包括增殖和迁移在内的所有 HMEC-1 活性。
C5a 诱导 HMEC-1 细胞的增殖、迁移和环状形成。针对 C5a 的特异性拮抗剂可有效抑制这些作用。我们的结果表明 C5a 参与了血管生成,并作为炎症性疾病治疗的有效靶点。